U.S. Food and Drug Administration; United States Food and Drug Administration; FDA; Food and Drug Administration (FDA); Food and Drug Administration

FDA Approves Esketamine Nasal Spray as Standalone Treatment for Depression

by
FDA Approves Esketamine Nasal Spray as Standalone Treatment for Depression

FDA Approves Spravato Nasal Spray‍ as Standalone Treatment for Major ⁢Depressive Disorder In a groundbreaking move, the U.S. food and Drug Governance (FDA) has approved a supplemental‌ new drug request for Spravato (esketamine) nasal spray, allowing it to be used as ⁤a standalone treatment for adults with major depressive⁢ disorder (MDD) who have not responded … Read more

Breakthrough PTSD Drug: New Hope on the Horizon?

by
Breakthrough PTSD Drug: New Hope on the Horizon?

New Hope for PTSD: Promising Drug Combination Shows Notable Enhancement Table of Contents New Hope for PTSD: Promising Drug Combination Shows Notable Enhancement A Much-Needed Advance ‌in ‌PTSD Treatment New PTSD Treatment Shows​ Promise in US Clinical Trial Safety and Side Effects A Broader Clinical Picture Expert Commentary and Future Directions Breakthrough Treatment Shows Promise … Read more